Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ALPHAMAB-ONCOLOGY-103501724/news/Alphamab-Oncology-Announces-the-First-Patient-Dosed-in-Australia-in-the-Clinical-Study-of-Subcutaneo-46291844/?utm_source=whatsapp&utm_medium=social&utm_campaign=share